kynurenic acid has been researched along with Dyskinesia, Medication-Induced in 4 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Excerpt | Relevance | Reference |
---|---|---|
"Kynurenic acid (KYNA) is a neuroactive metabolite that interacts with NMDA, AMPA/kainate and alpha 7 nicotinic receptors." | 1.42 | The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level. ( Bohar, Z; Horvath, G; Kekesi, G; Pardutz, A; Petrovszki, Z; Safrany-Fark, A; Tar, L; Tuboly, G; Vecsei, L, 2015) |
"This relationship is altered in Parkinsonism and in levodopa-induced dyskinesias (LID), resulting in an upregulation of corticostriatal glutamatergic function." | 1.33 | Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys. ( Bédard, PJ; Grégoire, L; Guidetti, P; Izzo, E; Rassoulpour, A; Samadi, P; Schwarcz, R, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tuboly, G | 1 |
Tar, L | 1 |
Bohar, Z | 1 |
Safrany-Fark, A | 1 |
Petrovszki, Z | 1 |
Kekesi, G | 1 |
Vecsei, L | 1 |
Pardutz, A | 1 |
Horvath, G | 1 |
Samadi, P | 2 |
Grégoire, L | 2 |
Rassoulpour, A | 2 |
Guidetti, P | 2 |
Izzo, E | 2 |
Schwarcz, R | 2 |
Bédard, PJ | 2 |
Di Paolo, T | 1 |
Robertson, RG | 1 |
Farmery, SM | 1 |
Sambrook, MA | 1 |
Crossman, AR | 1 |
4 other studies available for kynurenic acid and Dyskinesia, Medication-Induced
Article | Year |
---|---|
The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Disease Models, Animal; Dose-Response | 2015 |
Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dose- | 2005 |
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Drug Interactions; Dyskines | 2008 |
Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus.
Topics: Animals; Dyskinesia, Drug-Induced; Globus Pallidus; Kynurenic Acid; Macaca fascicularis; Receptors, | 1989 |